Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Cresemba - UCSF Infectious Diseases Management Program
UCSF Infectious Diseases Management Program · UCSF adult oral/IV isavuconazonium sulfate dosing, 372 mg prodrug per dose.
Renal method: Institutional intermittent and continuous hemodialysis tables. Source date: Online guidance checked 2026-11-07; section revision not established. Retrieved: 2026-11-07
Professional guidance with defined scope. Publication date, institutional setting and source limitations remain controlling. This is not automatic preference over another source.
UCSF lists 372 mg of isavuconazonium sulfate every 8 hours for six loading doses, then 372 mg daily. Its adult intermittent and continuous HD table retains that schedule. Check the prodrug versus active moiety and confirm the exact dialysis modality.
RDM73-cresemba-professional-1 · Source locator: Adult loading, maintenance and dialysis
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
